A detailed history of Dorchester Wealth Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dorchester Wealth Management CO holds 19,340 shares of BMY stock, worth $1.12 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
19,340
Previous 13,232 46.16%
Holding current value
$1.12 Million
Previous $549,000 82.15%
% of portfolio
0.18%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$39.66 - $51.75 $242,243 - $316,089
6,108 Added 46.16%
19,340 $1 Million
Q2 2024

Jul 23, 2024

SELL
$40.25 - $52.99 $44,194 - $58,183
-1,098 Reduced 7.66%
13,232 $549,000
Q1 2024

Apr 30, 2024

BUY
$47.98 - $54.4 $41,022 - $46,512
855 Added 6.35%
14,330 $777,000
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $5,769 - $6,884
-119 Reduced 0.88%
13,475 $691,000
Q3 2023

Oct 24, 2023

SELL
$57.89 - $64.73 $46,312 - $51,784
-800 Reduced 5.56%
13,594 $788,000
Q1 2023

Apr 26, 2023

BUY
$65.71 - $74.53 $183,987 - $208,684
2,800 Added 24.15%
14,394 $997,000
Q4 2022

Jan 31, 2023

SELL
$68.48 - $81.09 $208,864 - $247,324
-3,050 Reduced 20.83%
11,594 $834,000
Q2 2022

Aug 04, 2022

SELL
$72.62 - $79.98 $39,941 - $43,989
-550 Reduced 3.62%
14,644 $1.13 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $4,611 - $5,529
-75 Reduced 0.49%
15,194 $1.39 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $42,904 - $50,016
-800 Reduced 4.98%
15,269 $952,000
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $70,944 - $83,102
-1,199 Reduced 6.94%
16,069 $951,000
Q2 2021

Jul 22, 2021

SELL
$61.91 - $67.42 $230,614 - $251,139
-3,725 Reduced 17.74%
17,268 $1.15 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $47,293 - $53,191
797 Added 3.95%
20,993 $1.33 Million
Q4 2020

Jan 22, 2021

BUY
$57.74 - $65.43 $81,009 - $91,798
1,403 Added 7.47%
20,196 $1.25 Million
Q3 2020

Oct 19, 2020

SELL
$57.43 - $63.64 $6,432 - $7,127
-112 Reduced 0.59%
18,793 $1.13 Million
Q2 2020

Jul 20, 2020

BUY
$54.82 - $64.09 $83,764 - $97,929
1,528 Added 8.79%
18,905 $1.11 Million
Q1 2020

Apr 16, 2020

SELL
$46.4 - $67.43 $6,867 - $9,979
-148 Reduced 0.84%
17,377 $969,000
Q4 2019

Jan 21, 2020

SELL
$49.21 - $64.19 $92,416 - $120,548
-1,878 Reduced 9.68%
17,525 $1.13 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $42,641 - $50,557
-997 Reduced 4.89%
19,403 $984,000
Q3 2018

Oct 16, 2018

SELL
$55.19 - $62.25 $38,633 - $43,575
-700 Reduced 3.32%
20,400 $1.27 Million
Q1 2018

Apr 20, 2018

SELL
$59.92 - $68.98 $77,896 - $89,674
-1,300 Reduced 5.8%
21,100 $1.34 Million
Q4 2017

Jan 18, 2018

SELL
$59.94 - $65.35 $14,925 - $16,272
-249 Reduced 1.1%
22,400 $1.37 Million
Q3 2017

Oct 19, 2017

BUY
$55.23 - $63.74 $1.25 Million - $1.44 Million
22,649
22,649 $1.44 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dorchester Wealth Management CO Portfolio

Follow Dorchester Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorchester Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Dorchester Wealth Management CO with notifications on news.